Patents by Inventor Ofer SHAMNI

Ofer SHAMNI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Radiolabeled erlotinib analogs and uses thereof
    Patent number: 10710968
    Abstract: Radiolabeled compounds which are erlotinib analogs that feature a radioactive halogen and processes of preparing same are disclosed. Uses of these radiolabeled compounds in radioimaging, for identifying and monitoring a level, distribution and/or mutational status of deregulated EGFR, and/or in radiotherapy, are also disclosed.
    Type: Grant
    Filed: January 12, 2017
    Date of Patent: July 14, 2020
    Assignee: Hadasit Medical Research Services and Development Ltd.
    Inventors: Eyal Yosef Mishani, Ofer Shamni, Galith Rachel Abourbeh-Gofrit
  • RADIOLABELED ERLOTINIB ANALOGS AND USES THEREOF
    Publication number: 20190023664
    Abstract: Radiolabeled compounds which are erlotinib analogs that feature a radioactive halogen and processes of preparing same are disclosed. Uses of these radiolabeled compounds in radioimaging, for identifying and monitoring a level, distribution and/or mutational status of deregulated EGFR, and/or in radiotherapy, are also disclosed.
    Type: Application
    Filed: January 12, 2017
    Publication date: January 24, 2019
    Inventors: Eyal Yosef MISHANI, Ofer SHAMNI, Galith Rachel ABOURBEH-GOFRIT